This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

National Survey on Hypertension in General Practitioner (GP) Consultation (Prophyl GP)

This study has been completed.
Information provided by:
AstraZeneca Identifier:
First received: June 10, 2008
Last updated: August 4, 2009
Last verified: August 2009
To evaluate (with sufficient accuracy) the profile(demographic and clinical characteristics, health care management) of hypertensive patients seen in general practitioner consultation.


Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Profile of Hypertensive Patients Seen in General Practitioner Consultation

Further study details as provided by AstraZeneca:

Primary Outcome Measures:
  • Demographic, clinical and health care characteristics [ Time Frame: Once ]

Enrollment: 2853
Study Start Date: April 2008
Study Completion Date: November 2008


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
First three consecutive patients with hypertension seen by general practitioner

Inclusion Criteria:

  • male or female > or = 18 years old
  • Known hypertension
  • agree to take part in this study

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00695656

  Show 1387 Study Locations
Sponsors and Collaborators
Study Director: Castaigne, Medical Director AstraZeneca
  More Information

Responsible Party: Alain Castaigne, Medical Director, AstraZeneca Pharmaceuticals Identifier: NCT00695656     History of Changes
Other Study ID Numbers: NIS-CFR-DUM-2007/7
Study First Received: June 10, 2008
Last Updated: August 4, 2009

Keywords provided by AstraZeneca:
general practitioner consultation
Patients with hypertension

Additional relevant MeSH terms:
Vascular Diseases
Cardiovascular Diseases processed this record on September 21, 2017